Indiana University
Indiana University, Indiana Biosciences Research Institute Form Precision Medicine Center
The center will conduct research and advance precision medicines for diabetes, pediatric rare diseases, cancer, and Alzheimer's disease.
Hospitals Figuring Out How to Incorporate Beta-Amyloid Testing in Standard Clinical Practice
Premium
Spurred by newly available beta-amyloid-targeting drugs, hospitals are exploring how to diagnose Alzheimer's patients early and determine their treatment.
The test detects blood gene expression biomarkers that are predictive of high hallucination and high delusion states and future hospitalizations.
The availability of drugs to delay clinical type 1 diabetes onset makes risk screening critical, but the field is still working on how to implement it.
Presence of cfDNA, CTCs Predicts Recurrence in Triple-Negative Breast Cancer
Analyzing both circulating tumor DNA and circulating tumor cells, investigators could classify patients into groups with significantly higher and lower recurrence risk.